Clinical Trials Browser

Insulin Resistance × Tirzepatide × 90 days × Clear all

NCT07065552 2026-04-28

Tirzepatide in Obesity-Driven Endometrial Cancer

Phase EARLY_PHASE1 Recruiting

GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms